Cargando…

Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia

Mutations in CSF3R (colony-stimulating factor 3 receptor) are frequent oncogenic drivers in chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML). Here we describe a 75 year old man who was diagnosed with CSF3R-T618I-positive atypical CML. He presented with leukocytosis, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dao, Kim-Hien T., Solti, Magdolna B., Maxson, Julia E., Winton, Elliott F., Press, Richard D., Druker, Brian J., Tyner, Jeffrey W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145163/ https://www.ncbi.nlm.nih.gov/pubmed/25180155 http://dx.doi.org/10.1016/j.lrr.2014.07.002

Ejemplares similares

Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia
por: Khanna, Vishesh, et al.
Publicado: (2015)

Myeloid Disease with the CSF3R T618I Mutation after CLL
por: Couto, Maria Eduarda, et al.
Publicado: (2020)

Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report
por: Carratt, Sarah A., et al.
Publicado: (2021)

Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia
por: Watanabe-Smith, Kevin, et al.
Publicado: (2016)

Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia
por: Adam, Franziska C., et al.
Publicado: (2022)

Two myeloid leukemia cases with rare FLT3 fusions
por: Zhang, Haijiao, et al.
Publicado: (2018)

CSF3R T618I mutated chronic myelomonocytic leukemia: A proliferative subtype with a distinct mutational profile
por: Kwon, Adelaide, et al.
Publicado: (2022)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2019)

Anti-inflammatory effects of ruxolitinib on chronic neutrophilic leukemia harboring CSF3R-T618I mutation with bilateral renal abscesses
por: Sahara, Naohi, et al.
Publicado: (2022)

Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for CSF3R T618I Mutant Chronic Neutrophilic Leukemia
por: Ye, Peipei, et al.
Publicado: (2023)

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022)

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2022)

Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients
por: Rosenberg, Mara W., et al.
Publicado: (2020)

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes
por: Bezerra, Evandro D., et al.
Publicado: (2021)

Comprehensive molecular characterization of a rare case of Philadelphia chromosome–positive acute myeloid leukemia
por: Rosenberg, Mara W., et al.
Publicado: (2022)

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia
por: Rocca, Stefania, et al.
Publicado: (2018)

Eighty-year-old man with rare chronic neutrophilic leukemia caused by CSF3R T618I mutation: A case report and review of literature
por: Li, Ya-Ping, et al.
Publicado: (2020)

Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
por: Kurtz, Stephen E., et al.
Publicado: (2022)

Next‐generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia
por: Yun, Jae Won, et al.
Publicado: (2019)

CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis
por: Zhang, Xinmin, et al.
Publicado: (2022)

CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia
por: Menezes, J, et al.
Publicado: (2013)

Atypical Presentation of Acute Myeloid Leukemia
por: Agrawal, Kavita, et al.
Publicado: (2018)

Circulating miR-618 Has Prognostic Significance in Patients with Metastatic Colon Cancer
por: Radanova, Maria, et al.
Publicado: (2021)

Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia
por: Rice, William G., et al.
Publicado: (2022)

Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia
por: Oyogoa, Emmanuella, et al.
Publicado: (2023)

Atypical chronic myeloid leukemia with t(9;22)(p24,11.2), a BCR-JAK2 fusion gene
por: Bellesso, Marcelo, et al.
Publicado: (2013)

Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3 mutation-positive leukemia
por: Agarwal, Anupriya, et al.
Publicado: (2014)

A typical atypical chronic myeloid leukemia
por: Gilioli, Andrea, et al.
Publicado: (2018)

The mutational landscape of atypical chronic myeloid leukemia
por: Langabeer, Stephen E.
Publicado: (2019)

CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition
por: Swoboda, Anja S., et al.
Publicado: (2023)

Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome
por: Braun, Theodore P., et al.
Publicado: (2014)

In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia
por: Glover, Jason M, et al.
Publicado: (2012)

Targeting survivin and p53 in pediatric acute lymphoblastic leukemia
por: Tyner, J W, et al.
Publicado: (2012)

Atypical Chronic Myeloid Leukemia: Where Are We Now?
por: Crisà, Elena, et al.
Publicado: (2020)

Characteristics and survival of patients with atypical chronic myeloid leukemia
por: Kong, Jee Hyun, et al.
Publicado: (2019)

CCNP security firewall 642-618 quick reference
por: Sequeira, Anthony
Publicado: (2012)

MON-618 National In-Hospital Trends in Acquired Hypothyroidism
por: Kumar, Monisha Priyadarshini, et al.
Publicado: (2019)

MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF
por: Wang, Xin, et al.
Publicado: (2021)

PCM1-JAK2 Fusion in a Patient With Acute Myeloid Leukemia
por: Lee, Jong-Mi, et al.
Publicado: (2018)

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia
por: Li, Bing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dqbqleiidurrguf5ij47fl7t4a